These suggest that KS-cSCC-1 was derived from a CK10+++CK14+ tumor cell and KS-cSCC-2 from CK10−CK14+++ tumor cell in these heterogeneous cancer tissues. This evidence concerns the gene KRT10 and neoplasm.